Symbiotec Pharmalab Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 240.25 | 230.39 | 231.75 |
| Operating Expense | 160.04 | 151.60 | 216.95 |
| Net Profit | 48.54 | 47.01 | -15.69 |
| Net Profit Margin | 20.20% | 20.40% | -6.77% |
| Earning Per Share | 7.68 | 7.49 | -2.73 |
| EBIDTA | 80.48 | 78.80 | 15.19 |
| Effective Tax Rate | 21.12% | 20.33% | 88.65% |
Particulars
Sep 2026
Revenue240.25
Operating Expense160.04
Net Profit48.54
Net Profit Margin20.20
Earning Per Share7.68
EBIDTA80.48
Effective Tax Rate21.12
